In GBM, CD133, SSEA1, CD49f, Musashi-1, and nestin are considered to be glioma stem cell (GSC) markers.12, 14 We demonstrated a global change in tumor hallmarks upon silencing VDAC1 expression in GBM mouse models.11 This evidence concerns the gene VDAC1 and neoplasm.